ACIPIMOX
UNII K9AY9IR2SD

Substance Identification & Data

This profile provides standardized clinical and technical data for Acipimox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K9AY9IR2SD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 51037-30-0 and the RxNorm Concept ID (RxCUI) 16817. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K9AY9IR2SD

CAS Registry Number

51037-30-0

RxNorm Concept ID

16817

Detailed Substance Profile

Preferred Name

ACIPIMOX

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C6H6N2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DJQOOSBJCLSSEY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C72982

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5310993

Unique identification number in the NCBI database of chemical substances.

INN ID

3809

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[n+]1(cc(C(=O)O)ncc1C)[O-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Acipimox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.